Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,636.73
(
-1.18%
)
US TECH 100
23,889.60
(
-1.01%
)
Dow Jones
46,260.81
(
-1.56%
)
Brent Oil
105.79
(
5.11%
)
Bitcoin
71,210.04
(
-3.70%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: biomaven0 post# 129527

Thursday, 10/27/2011 12:25:26 AM

Thursday, October 27, 2011 12:25:26 AM

Post# of 257253

Of course INCY has argued precisely the opposite



Hmm...Maybe because theirs don't inhibit JAK3. PFE originally thought Tofacitinib was JAK3. Then it was corrected Tofacitinib is actually pan-JAK.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now